Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in Turkey

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 5, 2000, Pages 695-699

  Aksaray, Sebahat ^a   Dokuzoğuz, Başak ^a   Güvener, Engin ^a   Yücesoy, Mine ^b   Yuluğ, Nuran ^b   Kocagöz, Sesin ^c   Ünal, Serhat ^c   Çetin, Sıla ^d   Çalangu, Semra ^d   Günaydın, Murat ^e   Leblebicioğlu, Hakan ^e   Esen, Şaban ^e   Bayar, Banu ^f   Willke, Ayşe ^f   Fındık, Duygu ^g   Tuncer, İnci ^g   Baysal, Bülent ^g   Günseren, Filiz ^h   Mamıkoğlu, Latife ^h  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

^e ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^f ANKARA UNIVERSITY   (Turkey)

^g SELCUK UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^h AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFEPIME; CEFODIZIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; GRAM NEGATIVE BACTERIUM; INTENSIVE CARE UNIT; TURKEY (REPUBLIC);

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; TURKEY;

EID: 17144458753     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.5.695     Document Type: Article

References (11)

1. Günseren, F., Mamikoǧlu, L., Öztürk, S., Yucesoy, M., Biberoǧlu, K., Yulug, N. et al. (1999). A surveillance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey. Journal of Antimicrobial Chemotherapy 43, 373-8.
2. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA.
3. Livermore, D. M. & Yuan, M. (1996). Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. Journal of Antimicrobial Chemotherapy 36, 409-24.
4. Vincent, J. L., Bihari, D. J., Suter, P. M., Bruining, H. A., White, J., Nicolas-Chanoin, M. H. et al. (1995). The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. Journal of the American Medical Association 274, 639-44.
5. Verbist, L. (1993). Epidemiology and sensitivity of 8625 ICU and haematology/oncology bacterial isolates in Europe. Scandinavian Journal of Infectious Diseases Suppl. 91, 14-24.
6. Livermore, D. M. (1995). β-Lactamases in laboratory and clinical resistance. Clinical Microbiology Reviews 8, 557-84.
7. Duval, J., Soussy, C. J., Acar, J. F., Bergogne-Bérézin, E., Cluzel, R., Thabaut, A. et al. (1993). In-vitro antibacterial activity of cefepime: a multicentre study. Journal of Antimicrobial Chemotherapy 32, Suppl. B, 55-61.
8. Sirot, D. (1995). Extended-spectrum plasmid-mediated β-lactamases. Journal of Antimicrobial Chemotherapy 36, Suppl. A, 19-34.
9. Vahaboǧlu, H., Öztürk, R., Aygün, G., Cosurkan, F., Yaman, A., Kaygusuz, A. et al. (1997). Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrobial Agents and Chemotherapy 41, 2265-9.
10. Jacoby, G. A. & Medeiros, A. A. (1991). More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 35, 1697-704.
11. Livingstone, D., Gill, M. J. & Wise, R. (1995). Mechanisms of resistance to the carbapenems. Journal of Antimicrobial Chemotherapy 35, 1-5.